Changchun GeneScience Pharmaceutical Co., Ltd.
2 clinical trials · 2 recruiting · INDUSTRY
Trials by Changchun GeneScience Pharmaceutical Co., Ltd.
RECRUITINGPhase 2NCT06189495
A Randomized, Double-blind, Placebo-controlled Phase II Clinical Study to Evaluate the Safety, Tolerability, Efficacy,...
This study was conducted in a randomized, double-blind, placebo-controlled design to evaluate the efficacy and safety of Genakumab injection in the treatment of CTD-ILD including...
Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd.Enrolling: 304 locations
Systemic Sclerosis Associated Interstitial Lung DiseaseRheumatoid Arthritis Associated Interstitial Lung Disease (RA-ILD)Systemic Sclerosis Associated Interstitial Lung Disease (SSc-ILD)
RECRUITINGPhase 1NCT06569758
A Study of GenSci098 in Subjects With Active Thyroid Eye Disease
To evaluate the safety and tolerability of single and multiple ascending subcutaneous doses of GenSci098 in patients with thyroid eye disease (TED)
Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd.Enrolling: 761 location
SafetyTolerabilityGenSci098+1